Mucous membrane pemphigoid differs from pemphigus vulgaris or bullous pemphigoid in clinical course, response to steroid therapy, and absence of characteristic antibodies. In this studiy of five elderly patients, it was not possible to demonstrate antibodies to oral epithelium by direct or indirect immunofluorescent studies.
Beutner, E.H. , and Jordan, R.E.: Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients By Indirect Immunofluorescent Staining , Proc Soc Exp Biol Med117:505, 1964.
Chorzelski, T.; Jablonska, S.; and Blasz-Czyk , M.: Immunopathological Investigations in the Senear-Usher Syndrome (Coexistence of Pemphigus and Lupus Erythematosus), Brit J Derm80:211, 1968.
5.
McKinney, R.M. ; Spillane, J.T.; and Pearce, G.W.: Factors Affecting the Rate of Reaction of Fluorescein Isothiocyanate With Serum Proteins, J Immun93:232, 1964.
6.
Spendlove, R.S. : Optimal Labeling of Antibody With Fluorescein Isothiocyanate, Proc Soc Exp Biol Med122:580, 1966.
7.
Beutner, E.H. ; Jordan, R.E.; and Chorzelski , T.P.: The Immunopathology of Pemphigus and Bullous Pemphigoid, J Invest Derm, 51:63, 1968.
8.
Mackay, I.R., and Burnet, F.M.: Autoimmune Diseases, Springfield, Ill: Charles C Thomas, 1964.
